- Home
- XTLB vs AMST Comparison
XTLB vs AMST Comparison
Compare XTLB & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- AMST
- Stock Information
- Founded
- XTLB 1993
- AMST 2017
- Country
- XTLB Israel
- AMST United States
- Employees
- XTLB N/A
- AMST N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- XTLB Health Care
- AMST Technology
- Exchange
- XTLB Nasdaq
- AMST Nasdaq
- Market Cap
- XTLB 8.0M
- AMST 7.4M
- IPO Year
- XTLB 2005
- AMST 2020
- Fundamental
- Price
- XTLB $1.83
- AMST $2.36
- Analyst Decision
- XTLB
- AMST
- Analyst Count
- XTLB 0
- AMST 0
- Target Price
- XTLB N/A
- AMST N/A
- AVG Volume (30 Days)
- XTLB 109.8K
- AMST 18.3K
- Earning Date
- XTLB 11-26-2024
- AMST 11-14-2024
- Dividend Yield
- XTLB N/A
- AMST N/A
- EPS Growth
- XTLB N/A
- AMST N/A
- EPS
- XTLB N/A
- AMST N/A
- Revenue
- XTLB N/A
- AMST $114,798.00
- Revenue This Year
- XTLB N/A
- AMST N/A
- Revenue Next Year
- XTLB N/A
- AMST N/A
- P/E Ratio
- XTLB N/A
- AMST N/A
- Revenue Growth
- XTLB N/A
- AMST N/A
- 52 Week Low
- XTLB $0.76
- AMST $1.72
- 52 Week High
- XTLB $4.99
- AMST $4.34
- Technical
- Relative Strength Index (RSI)
- XTLB 46.62
- AMST 39.69
- Support Level
- XTLB $1.70
- AMST $2.31
- Resistance Level
- XTLB $1.85
- AMST $2.49
- Average True Range (ATR)
- XTLB 0.13
- AMST 0.17
- MACD
- XTLB 0.01
- AMST -0.05
- Stochastic Oscillator
- XTLB 42.58
- AMST 7.25
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.